HR 649, the Whole Milk for Healthy Kids Act of 2025, amends the National School Lunch Act to allow schools participating in the program to offer students both organic and non-organic whole milk, in addition to reduced-fat, low-fat, and fat-free options. Key provisions include clarifying that milk fat in whole milk should not count toward saturated fat limits for meal compliance, prohibiting schools from purchasing milk from Chinese state-owned enterprises, and ensuring schools cannot be barred from offering the full range of milk types listed. The bill directly affects public and private schools serving the National School Lunch Program by expanding their milk options for students. It focuses on concrete policy changes to dietary offerings and sourcing restrictions within the school nutrition program.
HRES 473 is a non-binding House resolution calling on the U.S. government to urgently use diplomatic efforts to ensure food and medical supplies reach civilians in Gaza. It directly addresses the needs of approximately 2.2 million Palestinians facing acute hunger, including 10,000 children identified with acute malnutrition, following a border blockade that blocked aid from March to May 2025. The resolution specifically urges the White House and State Department to secure "immediate and secure delivery and disbursement" of aid and a lasting end to the conflict, citing collapsed bakeries, exhausted food rations, and a near-total health system collapse.
The Cure Hepatitis C Act of 2025 establishes a national program to eliminate hepatitis C virus in the United States by providing free treatment to people with hepatitis C who are in correctional facilities, enrolled in Medicaid or CHIP programs, receiving care through Indian Health Services, or without health insurance. The bill creates a subscription program where the Secretary of Health and Human Services will purchase and distribute hepatitis C treatments directly to covered populations without cost-sharing, while also establishing a national strategy, implementation plan, and public dashboard to monitor progress. It includes $5.5 billion for treatment access and $4.283 billion for public health activities like screening, diagnosis, and community outreach to improve hepatitis C treatment outcomes. The program requires participation from the Bureau of Prisons and Indian Health Service, and aims to coordinate care across health systems to eliminate hepatitis C virus.
This bill modifies U.S. tax rules for distilled spirits, specifically affecting Puerto Rico. It repeals a previous restriction on redirecting taxes collected from rum imported into the U.S. back to Puerto Rico, and requires Puerto Rico to transfer a portion of those rum tax revenues to the Puerto Rico Conservation Trust Fund. The transfer amount equals at least 1/6 of the difference between $10.50 per proof gallon and the actual tax rate (capped at $13.25 per gallon). The fund, established in 1968, uses these funds for conservation efforts like protecting natural areas and restoring habitats in Puerto Rico.
This bill (S 1949) creates new penalties for manufacturing or distributing candy-flavored drugs marketed to minors. It specifically targets producers who combine schedule I or II controlled substances with candy/beverage products, market them to appear like candy, or modify them with candy-like flavors/coloring, knowing they’ll be sold to people under 18. First offenses carry up to 10 additional years in prison, while repeat offenses carry up to 20 additional years. Exceptions apply for FDA-approved medications sold as prescribed and products altered under a doctor’s direction for legitimate medical use.
Strengthening Agency Management and Oversight of Software Assets Act This bill requires federal agencies to assess their software inventory and develop software management plans. The bill requires each agency (which includes any executive department, military department, or other establishment in the executive branch) to complete a comprehensive assessment of the software paid for by, in use at, or deployed throughout the agency. The assessment must include information such as (1) the current inventory of software; (2) contracts and other arrangements used to acquire, build, deploy, or use the software; (3) costs and fees not included in the initial contract or agreement; and (4) the interoperability of the software and restrictions on its use. Each agency must use their assessment to develop a plan to consolidate software entitlements, develop procedures for cost-effective acquisition strategies, and restrict subordinate entities from using any software entitlement without approval. (A software entitlement is software that has been purchased, leased, or licensed by or billed to an agency and that is subject to use limitations.) Such plans must be submitted to the Office of Management and Budget (OMB) and Congress. Within two years of enactment, OMB must submit recommendations to Congress regarding government software procurement policies and practices to • increase the interoperability of software licenses, • consolidate licenses when appropriate, • reduce costs, • improve performance, and • modernize the management and oversight of agency software. The GAO must report on certain related topics, including governmentwide trends in agency software asset management practices and comparisons of such practices among agencies.
The Family Vaccine Protection Act makes the Advisory Committee on Immunization Practices (ACIP) an official part of federal law, requiring it to provide vaccine recommendations based on strong scientific evidence. It mandates that the CDC Director must adopt ACIP's recommendations unless they don't meet the evidence standard, and if not adopted, the CDC must explain its decision and notify Congress within 48 hours. The bill establishes procedures for ACIP to review new vaccines within 90 days of licensure and to consider breakthrough therapies or public health emergencies. This act aims to strengthen transparency and evidence-based decision-making in vaccine recommendations for the public health system. It affects the CDC, ACIP, and Congress through formalized processes for vaccine policy development.
This resolution designates June as "Life Month" each year, recognizing the inherent dignity of all human life. It urges Congress to acknowledge that every life is a sacred gift and to commend organizations and individuals supporting pregnant mothers and families. The resolution does not create new laws or policies but serves as a symbolic statement affirming life as a fundamental right.
HRES 465 is a resolution expressing the House of Representatives' support for Congress to enact the Older Americans Bill of Rights. It calls for future legislation establishing specific rights for older Americans, including access to dignified healthcare (like affordable prescriptions and caregiver support), financial security (such as strengthened Social Security), and community participation (like accessible housing and voting). The resolution itself does not create new laws but urges Congress to draft such a bill. It directly addresses older Americans, particularly those facing poverty, health disparities, or isolation, based on cited statistics about their challenges.
S 1933 (Informing VETS Act of 2025) requires the Department of Veterans Affairs to send each eligible veteran a letter explaining their educational benefits and provide a clear comparison of those benefits against the GI Bill (Chapter 33) both in the letter and on a public website. This directly affects veterans transitioning from military service who are entitled to education programs under Title 38. The key mechanism is mandating regular, standardized information about benefit options to help veterans make informed decisions. The policy change focuses on improving transparency and accessibility of educational benefit information for veterans.
The Small Biotech Innovation Act exempts qualifying drugs from Medicare's drug price negotiation program starting in 2029 for small biotech manufacturers that meet specific R&D investment thresholds. To qualify, a company must have five or fewer single-source drugs and spend 30% to 70% of its net revenue on research and development (based on the number of drugs), while not being controlled by a foreign government. Manufacturers must apply annually with financial data and certification of R&D spending, and the exemption ends if the company is acquired by a non-qualifying entity after 2029. This directly affects small U.S.-based biotech firms developing innovative drugs, allowing them to avoid price negotiations under Medicare.
HR 3694, the VALID Act of 2025, requires lenders to include specific information about VA loans in mortgage disclosures. It amends the National Housing Act to mandate that disclosures state the loan-to-value ratio and clarify that VA loans are available under Chapter 37 of Title 38 (veterans' benefits law), assuming prevailing interest rates. The bill also requires the Federal Housing Finance Agency to add a military service question to the Uniform Residential Loan Application form, placing it above the signature line within six months of enactment. This directly affects veterans and active-duty service members applying for VA-guaranteed mortgages, as well as the lenders processing those applications.
